120 related articles for article (PubMed ID: 22390489)
1. FcγRIIB: a modulator of cell activation and humoral tolerance.
Lehmann B; Schwab I; Böhm S; Lux A; Biburger M; Nimmerjahn F
Expert Rev Clin Immunol; 2012 Mar; 8(3):243-54. PubMed ID: 22390489
[TBL] [Abstract][Full Text] [Related]
2. Fc-receptors as regulators of immunity.
Nimmerjahn F; Ravetch JV
Adv Immunol; 2007; 96():179-204. PubMed ID: 17981207
[TBL] [Abstract][Full Text] [Related]
3. FcγRIIB and autoimmunity.
Espéli M; Smith KG; Clatworthy MR
Immunol Rev; 2016 Jan; 269(1):194-211. PubMed ID: 26683154
[TBL] [Abstract][Full Text] [Related]
4. Antibody-mediated modulation of immune responses.
Nimmerjahn F; Ravetch JV
Immunol Rev; 2010 Jul; 236():265-75. PubMed ID: 20636822
[TBL] [Abstract][Full Text] [Related]
5. Association of the FcγRIIB-nt645+25A/G polymorphism with the expression level of the FcγRIIb receptor, the antibody response to Porphyromonas gingivalis and the severity of periodontitis.
Sugita N; Iwanaga R; Kobayashi T; Yoshie H
J Periodontal Res; 2012 Feb; 47(1):105-13. PubMed ID: 21906057
[TBL] [Abstract][Full Text] [Related]
6. Dissection of the signalling mechanisms underlying FcgammaRIIB-mediated apoptosis of mature B-cells.
Carter NA; Harnett MM
Biochem Soc Trans; 2004 Dec; 32(Pt 6):973-5. PubMed ID: 15506939
[TBL] [Abstract][Full Text] [Related]
7. CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction.
Tedder TF; Poe JC; Haas KM
Adv Immunol; 2005; 88():1-50. PubMed ID: 16227086
[TBL] [Abstract][Full Text] [Related]
8. Suppression of Th2-driven airway inflammation by allergen immunotherapy is independent of B cell and Ig responses in mice.
Shirinbak S; Taher YA; Maazi H; Gras R; van Esch BC; Henricks PA; Samsom JN; Verbeek JS; Lambrecht BN; van Oosterhout AJ; Nawijn MC
J Immunol; 2010 Oct; 185(7):3857-65. PubMed ID: 20802147
[TBL] [Abstract][Full Text] [Related]
9. Lower antibody response to Porphyromonas gingivalis associated with immunoglobulin G Fcgamma receptor IIB polymorphism.
Honma Y; Sugita N; Kobayashi T; Abiko Y; Yoshie H
J Periodontal Res; 2008 Dec; 43(6):706-11. PubMed ID: 18705654
[TBL] [Abstract][Full Text] [Related]
10. FcgammaRIIB as a modulator of autoimmune disease susceptibility.
Tarasenko T; Dean JA; Bolland S
Autoimmunity; 2007 Sep; 40(6):409-17. PubMed ID: 17729034
[TBL] [Abstract][Full Text] [Related]
11. A role of FcgammaRIIB in the development of collagen-induced arthritis.
Nakamura A; Takai T
Biomed Pharmacother; 2004 Jun; 58(5):292-8. PubMed ID: 15194165
[TBL] [Abstract][Full Text] [Related]
12. Porcine Fc gamma RIIb sub-isoforms are generated by alternative splicing.
Xia P; Liu X; Zhang Y; Duan E; Zhang Z; Chen J; Mu C; Cui B
Vet Immunol Immunopathol; 2012 Jan; 145(1-2):386-94. PubMed ID: 22226426
[TBL] [Abstract][Full Text] [Related]
13. Characterization of SM201, an anti-hFcγRIIB antibody not interfering with ligand binding that mediates immune complex dependent inhibition of B cells.
Rieth N; Carle A; Müller MA; ter Meer D; Direnberger C; Pohl T; Sondermann P
Immunol Lett; 2014 Aug; 160(2):145-50. PubMed ID: 24472604
[TBL] [Abstract][Full Text] [Related]
14. Fcgamma receptors: old friends and new family members.
Nimmerjahn F; Ravetch JV
Immunity; 2006 Jan; 24(1):19-28. PubMed ID: 16413920
[TBL] [Abstract][Full Text] [Related]
15. FcgammaRIIB inhibits the development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
Zhao M; Wigren M; Dunér P; Kolbus D; Olofsson KE; Björkbacka H; Nilsson J; Fredrikson GN
J Immunol; 2010 Mar; 184(5):2253-60. PubMed ID: 20097865
[TBL] [Abstract][Full Text] [Related]
16. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
Peggs KS; Quezada SA; Allison JP
Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
Majlessi L; Bordenave G
Arch Immunol Ther Exp (Warsz); 2001; 49(6):407-15. PubMed ID: 11814234
[TBL] [Abstract][Full Text] [Related]
18. Allelic-dependent expression of an activating Fc receptor on B cells enhances humoral immune responses.
Li X; Wu J; Ptacek T; Redden DT; Brown EE; Alarcón GS; Ramsey-Goldman R; Petri MA; Reveille JD; Kaslow RA; Kimberly RP; Edberg JC
Sci Transl Med; 2013 Dec; 5(216):216ra175. PubMed ID: 24353158
[TBL] [Abstract][Full Text] [Related]
19. Low-level signaling generated by FcgammaRIIB-B cell receptor co-ligation establishes a state of global B cell receptor nonresponsiveness.
Preissler MT; Kaiser L; Drake JR; Gosselin EJ
Immunol Invest; 2005; 34(1):53-70. PubMed ID: 15773572
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous engagement of FcgammaIIb and CD22 inhibitory receptors silences targeted B cells and suppresses autoimmune disease activity.
Mihaylova N; Voynova E; Tchorbanov A; Dolashka-Angelova P; Bayry J; Devreese B; Kaveri S; Vassilev T
Mol Immunol; 2009 Nov; 47(1):123-30. PubMed ID: 19243823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
